Bayan Health review
An injection and an oral drop carry the same monthly figure here, which is the reverse of the usual pattern.
The verdict
Bayan Health prices compounded semaglutide at $99 and compounded tirzepatide at $119, and charges the same for the injectable microdose as for the oral drops. Both entry tiers are microdoses rather than the doses the approved labels describe.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection · Oral
- Dose pricing
- Flat across doses
- Injection
- From $129/mo
- Oral
- From $99/mo
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
Bayan Health sells compounded semaglutide and compounded tirzepatide in two delivery routes. The injectable microdose tiers read $99 and $119 a month. The oral drop formulations carried the same two figures on the same day. Both injectables are sold with vitamin B6 in the preparation. Billing is described as a monthly subscription.
Who writes the prescription, and what do they see?
A prescription stands behind every tier, and the subscription is the unit that is billed. The pages priced here describe the formulation and the route in detail. Who reviews an intake, and how often afterwards, is not published. No list of states served is published either, so eligibility is settled at intake rather than before it.
Treatment is arranged remotely and the medication arrives by mail. The microdose tier is the entry product on both routes. A microdose is a fraction of the maintenance dose each label describes. The published trial results for these molecules were produced at label doses.
What happens when the dose goes up?
The rate is stated as flat across doses, on both molecules and both routes. A titration therefore leaves the monthly figure where it started. What a dose step means on the oral route is a separate question from what it means by injection. Sublingual milligrams and injected milligrams are not interchangeable, and no conversion between them is published beside the price.
What the price includes
$99 buys either the injectable microdose or the oral drops, which inverts the usual order. Most sellers price an oral preparation above the injection. Tirzepatide is $119 by either route, so the $20 step between molecules holds whichever is chosen. No second charge sits beside either figure.
What it claims, and what it cites
Both molecules are compounded, so a pharmacy prepares them and no regulator reviews the finished product before it ships. The oral drops are the weaker case on evidence. Bayan publishes no pharmacokinetic data for that route. How much of a sublingual drop reaches the bloodstream is therefore not measured.
Where it holds up, and where it does not
- Strength: Injection and oral priced the same
- Strength: Rate stated as flat at every dose
- Strength: Two molecules on one page
- Limitation: No pharmacokinetic data published for the drops
- Limitation: State coverage not published
- Limitation: Entry tiers sit below label doses
What the evidence says about this kind of treatment
The assessment above is about Bayan Health. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- A reader weighing an injection against an oral preparation at one seller, where the two routes carry the same monthly figure.
- Wrong for
- A reader who wants the dose to match what the trials used, because both entry tiers here are microdoses rather than label doses.
The evidence behind what Bayan Health prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How Bayan Health compares
| Seller | Who it suits | Go |
|---|---|---|
 Idgie Health | A reader who wants a seller to say plainly that a microdose is an off-label use before taking a payment for one. | See Idgie Health → |
| Apex MD | A reader who wants a month-to-month plan with no prepay commitment, and who is told what is in the vial before ordering. | See Apex MD → |
 Collective | A reader who will stay on treatment for a full twelve months, which is the term the annual membership is priced against. | See Collective → |
More GLP-1 telehealth sellers reviews: MadeMedMANÜ TelehealthMarek HealthMavesMaximusMaxLife
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Are the oral drops equivalent to the injection?
- Equivalence is not established. No pharmacokinetic data for the drop route is published beside the price. Sublingual milligrams and injected milligrams are not interchangeable.
- What does a microdose tier mean here?
- It is a dose below the maintenance doses the approved labels describe. The trial results published for semaglutide and tirzepatide were produced at those label doses. A microdose was not what those trials measured.
- Does the price move as the dose rises?
- Bayan states one rate at every dose, on both molecules and both routes. The monthly figure therefore holds through a titration.
- Is Bayan Health expensive compared with other GLP-1 telehealth sellers?
- Bayan Health publishes a starting figure of $99/mo. Across the 402 GLP-1 telehealth sellers we review that publish a single monthly figure, those run $49 to $525.42 with a median of $190, which puts Bayan Health below the median, toward the cheaper end. The other 178 GLP-1 telehealth sellers we review quote only after an intake or price by dose, so they are not in that comparison. A starting figure is not a bill — labs, consultations and shipping are often charged separately, so confirm what your own quote includes.